This book addresses new challenges in toxicological risk assessment, including nanomaterials, endocrine disruptors, and computational toxicology. It covers innovative approaches and tools for evaluating emerging risks. The text emphasizes adapting regulatory science to keep pace with technological advancements. Ideal for toxicologists and regulators, it highlights future considerations in risk assessment.
Layne Boyle explores emerging issues in toxicological risk assessment within the field of regulatory science, addressing new challenges and advancements in evaluating chemical safety. His research focuses on integrating innovative methodologies, such as in vitro testing and computational modeling, into traditional risk assessment frameworks to improve accuracy and efficiency. Layne has developed strategies to address complex toxicological scenarios involving mixtures, low-dose exposures, and novel chemicals. He has published extensively on the evolution of risk assessment practices and the incorporation of new scientific insights into regulatory decision-making. As an editor, Layne provides guidelines for toxicologists and regulatory scientists to adopt cutting-edge risk assessment techniques, promoting robust and adaptive regulatory frameworks through informed toxicological practices.